Impact of baseline performance status on survival and toxicity with ipilimumab plus nivolumab: A 10-year institutional experience across solid tumors.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: University of Nebraska Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162687977
